Emerging World Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2009	FY 2007	FY 2006	FY 2005
Period Ending	Sep '10 Sep 30, 2010	Dec '09 Dec 31, 2009	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Net Income	-0.22	-0.06	-0.29	-0.2	-0
Depreciation & Amortization	-	-	0.05	-	-
Stock-Based Compensation	-	-	0.01	-	-
Change in Accounts Payable	-	-	-	-0	0
Change in Other Net Operating Assets	0.14	0.04	0.03	-	-
Operating Cash Flow	-0.07	-0.01	-0.21	-0.2	-0
Cash Acquisitions	-	-	-0.28	-	-
Investment in Securities	-1.79	-0.8	-	-	-
Investing Cash Flow	-1.79	-0.8	-0.28	-	-
Short-Term Debt Issued	-	0.81	-	-	-
Total Debt Issued	1.96	0.81	-	-	-
Net Debt Issued (Repaid)	1.96	0.81	-	-	-
Issuance of Common Stock	0.02	-	0.5	0.2	0
Financing Cash Flow	1.98	0.81	0.5	0.2	0
Miscellaneous Cash Flow Adjustments	-	-	0	-	-
Net Cash Flow	0.12	-	0.01	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.